Clarisonic acquired by L'Oréal
L'Oréal has signed a deal to acquire Pacific Bioscience Laboratories (PBL), the manufacturer of the Clarisonic line of skincare devices. Clarisonic is the market leader in the home skincare devices market - a sector which is expected to show considerable growth over the next few years. The devices are based around the use of sonically oscillating brushes and infusion technology and are used in professional treatments by dermatologists and salon therapists. They are also available for sale directly to consumers. PBL has 300 employees and recently relocated to a new corporate headquarters and manufacturing facility in Washington, US. L'Oréal USA's president and chief executive Frédéric Rozé said: 'This is a strategic acquisition for L'Oréal. Devices are rapidly emerging globally as an important new skincare category. He added: 'Clarisonic is successful and the fast growing premium brand in this segment. We think that together with PBL, we will create in Redmond an outstanding centre of innovation for L'Oréal.' The merger is subject to the approval of PBL's shareholders and is expected to close in December.